SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Piramal Enterprises

Piramal Enterprises

BSE: 500302|NSE: PEL|ISIN: INE140A01024|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Feb 28, 09:31
1848.15
-5.45 (-0.29%)
VOLUME 75
LIVE
NSE
Feb 28, 09:32
1849.20
-0.5 (-0.03%)
VOLUME 3,732
News on Piramal Enterprises
Select Year: 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Piramal Enterprises: Principal & payment of interest

9.12 am | 25 Feb 2017 |  Source: Moneycontrol.com

Piramal Enterprises has informed regarding ...

PFM okays two projects of Rs 1,020 cr under flexi LRD scheme

12.32 pm | 15 Feb 2017 |  Source: PTI

The firm has approved Rs 440 crore for Wadhwa Group's commercial project in BKC in the megapolis while the second investment is of Rs 580 crore agains...

Piramal Enterprises Q3 net profit up 32% at Rs 404.08 cr

4.08 pm | 13 Feb 2017 |  Source: PTI

The company had posted a net profit after non controlling interest and share of profit (loss) of associates and joint ventures of Rs 306.91 crore for ...

Market Week Ahead: Consolidation likely as focus shifts from earnings to elections

2.48 pm | 11 Feb 2017 |  Source: Moneycontrol.com

Mild correction may be seen in the week ahead as the market seems to have priced in earnings that were not affected by the note ban in November, even ...

Piramal Enterprises Q3 results on Feb 13, 2017

9.49 pm | 06 Feb 2017 |  Source: Moneycontrol.com

Piramal Enterprises board meeting will be held on February 13, 2017, to consider and approve the Unaudited Financial Results (Consolidated and Standal...

Piramal Enterprises to demerge healthcare, financial services

9.18 am | 31 Jan 2017 |  Source: PTI

In the medium term we will do that. All our acquisitions, and in some ways moving up in value chains and getting more critical mass are steps towards ...

Piramal buys US co's drug portfolio for USD 171 million

4.30 pm | 30 Jan 2017 |  Source: Moneycontrol.com

Piramal will also pay an additional USD 32 million – depending on financial performance of the acquired assets over the next 3 years....

Piramal to acquire drugs from UK's Mallinckrodt for Rs 1,162cr 

1.58 pm | 30 Jan 2017 |  Source: PTI

The company's UK-based wholly-owned subsidiary Piramal Critical Care has entered into an agreement with Mallinckrodt for acquiring the drugs and may a...

Piramal Enterprises acquires portfolio of drugs from Mallinckrodt LLC

1.33 pm | 30 Jan 2017 |  Source: Moneycontrol.com

Piramal Enterprises wholly owned Critical Care subsidiary in the UK has entered into an agreement to acquire a portfolio of intrathecal spasticity an...

Top buzzing midcap stocks to trade on January 30 

12.37 pm | 30 Jan 2017 |  Source: CNBC-TV18

Here are a few top buzzing midcap stocks picked by CNBC-TV18's analysts in trade today – Idea Cellular, BEL, Tata Coffee, Granules India, Just Dial,...

Buy Piramal Enterprises on declines: Prakash Gaba 

4.22 pm | 20 Jan 2017 |  Source: CNBC-TV18

Prakash Gaba of prakashgaba.com is of the view that one may buy Piramal Enterprises on declines....

Piramal Enterprises Q2 net up 30% at Rs 306 cr

4.54 pm | 27 Oct 2016 |  Source: PTI

Piramal Enterprises today reported 30.18 per cent rise in consolidated net profit to Rs 306.36 crore for the quarter ended September 30, 2016-17, on r...

Buy Piramal Enterprises; target of Rs 2400: Dynamic Levels

12.15 pm | 29 Sep 2016 |  Source: Moneycontrol.com

Dynamic Levels is bullish on Piramal Enterprises has recommended buy rating on the stock with a target price of Rs 2400 in its research report dated S...

1 2
Quick Links for Piramal Enterprises
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.